• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国糖尿病患者的糖尿病视网膜病变及相关临床实践:一项 10 年趋势分析。

Diabetic Retinopathy and Related Clinical Practice for People with Diabetes in Korea: A 10-Year Trend Analysis.

机构信息

Department of Ophthalmology, Ajou University School of Medicine, Suwon, Korea.

Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea.

出版信息

Diabetes Metab J. 2020 Dec;44(6):928-932. doi: 10.4093/dmj.2020.0096. Epub 2020 Jul 10.

DOI:10.4093/dmj.2020.0096
PMID:32662253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7801767/
Abstract

We performed a retrospective cohort study including people diagnosed with diabetes from 2006 to 2015 according to the Korean National Health Insurance Service-National Sample Cohort database, to analyze the changes in the prevalence, screening rate, and treatment patterns for diabetic retinopathy (DR) over 10 years. The proportion of people who underwent fundus screening for DR steadily increased over the past decade. The prevalence of DR increased from 13.4% in 2006 to 15.9% in 2015, while that of proliferative DR steadily decreased from 1.29% in 2006 to 1.16% in 2015. The proportion of patients undergoing retinal photocoagulation constantly decreased. The prevalence of DR increased over the past decade, while its severity seemed to have improved, with a decreased rate of proliferative DR and retinal photocoagulation. A higher proportion of patients underwent ophthalmic screening using fundus examination, but still less than 30% of patients with diabetes underwent comprehensive examination in 2015.

摘要

我们进行了一项回顾性队列研究,纳入了 2006 年至 2015 年根据韩国国家健康保险服务-国家样本队列数据库诊断为糖尿病的患者,以分析 10 年来糖尿病视网膜病变(DR)的患病率、筛查率和治疗模式的变化。过去十年中,眼底筛查 DR 的比例稳步上升。DR 的患病率从 2006 年的 13.4%上升到 2015 年的 15.9%,而增殖性 DR 的患病率从 2006 年的 1.29%稳步下降到 2015 年的 1.16%。视网膜光凝治疗的比例持续下降。过去十年中,DR 的患病率有所上升,但严重程度似乎有所改善,增殖性 DR 和视网膜光凝的比例有所下降。更多的患者接受了眼底检查的眼科筛查,但 2015 年仍有不足 30%的糖尿病患者接受了全面检查。

相似文献

1
Diabetic Retinopathy and Related Clinical Practice for People with Diabetes in Korea: A 10-Year Trend Analysis.韩国糖尿病患者的糖尿病视网膜病变及相关临床实践:一项 10 年趋势分析。
Diabetes Metab J. 2020 Dec;44(6):928-932. doi: 10.4093/dmj.2020.0096. Epub 2020 Jul 10.
2
Trends in diabetic retinopathy and related medical practices among type 2 diabetes patients: Results from the National Insurance Service Survey 2006-2013.2006-2013 年国家保险服务调查:2 型糖尿病患者中糖尿病视网膜病变及相关医疗实践的趋势。
J Diabetes Investig. 2018 Jan;9(1):173-178. doi: 10.1111/jdi.12655. Epub 2017 Jun 15.
3
Trends in Diabetic Retinopathy, Visual Acuity, and Treatment Outcomes for Patients Living With Diabetes in a Fundus Photograph-Based Diabetic Retinopathy Screening Program in Bangladesh.孟加拉国基于眼底照片的糖尿病视网膜病变筛查项目中糖尿病患者的糖尿病视网膜病变、视力和治疗结果趋势。
JAMA Netw Open. 2019 Nov 1;2(11):e1916285. doi: 10.1001/jamanetworkopen.2019.16285.
4
[Screening for diabetic retinopathy by non-mydriatic fundus photography: First national campaign in Lebanon].[通过免散瞳眼底照相术筛查糖尿病视网膜病变:黎巴嫩首次全国性活动]
J Fr Ophtalmol. 2019 Mar;42(3):288-294. doi: 10.1016/j.jfo.2018.12.005. Epub 2019 Mar 8.
5
Prevalence and risk factors for diabetic retinopathy: the Korea National Health and Nutrition Examination Survey 2008-2011.糖尿病视网膜病变的患病率及危险因素:韩国 2008-2011 年健康与营养调查。
Invest Ophthalmol Vis Sci. 2013 Oct 17;54(10):6827-33. doi: 10.1167/iovs.13-12654.
6
Diabetic retinopathy screening and treatment through the Brazilian National Health Insurance.通过巴西国家健康保险进行糖尿病视网膜病变筛查和治疗。
Sci Rep. 2022 Aug 17;12(1):13941. doi: 10.1038/s41598-022-18054-6.
7
Prevalence and factors associated with diabetic retinopathy in a Korean adult population: the 2008-2009 Korea National Health and Nutrition Examination Survey.韩国成年人群中糖尿病视网膜病变的患病率及相关因素:2008 - 2009年韩国国家健康与营养检查调查
Diabetes Res Clin Pract. 2013 Dec;102(3):218-24. doi: 10.1016/j.diabres.2013.10.016. Epub 2013 Nov 2.
8
A decade-long telemedicine screening program for diabetic retinopathy in the north-east of Italy.意大利东北部长达十年的糖尿病视网膜病变远程医疗筛查项目。
J Diabetes Complications. 2017 Aug;31(8):1348-1353. doi: 10.1016/j.jdiacomp.2017.04.010. Epub 2017 Apr 13.
9
Association between daily sunlight exposure duration and diabetic retinopathy in Korean adults with diabetes: A nationwide population-based cross-sectional study.韩国成年糖尿病患者的日常阳光暴露时间与糖尿病视网膜病变的相关性:一项全国性基于人群的横断面研究。
PLoS One. 2020 Aug 7;15(8):e0237149. doi: 10.1371/journal.pone.0237149. eCollection 2020.
10
Non-mydriatic fundus camera screening with diagnosis by telemedicine for diabetic retinopathy patients with type 1 and type 2 diabetes: a hospital-based cross-sectional study.1型和2型糖尿病视网膜病变患者通过远程医疗进行非散瞳眼底相机筛查及诊断:一项基于医院的横断面研究。
Ann Saudi Med. 2019 Sep-Oct;39(5):328-336. doi: 10.5144/0256-4947.2019.328. Epub 2019 Oct 3.

引用本文的文献

1
Ten-Year Trends of Fluorescein Angiography in Korea Using Data From the Health Insurance Review and Assessment Service.利用健康保险审查与评估服务机构的数据对韩国荧光素血管造影术的十年趋势分析
J Korean Med Sci. 2025 Apr 14;40(14):e39. doi: 10.3346/jkms.2025.40.e39.
2
The effect of sarpogrelate compared to aspirin in high- or very-high-risk diabetes for primary prevention.沙格雷酯与阿司匹林相比对高危或极高危糖尿病患者一级预防的效果。
Sci Rep. 2025 Jan 29;15(1):3616. doi: 10.1038/s41598-025-87868-x.
3
Trends in prescribing sodium-glucose cotransporter 2 inhibitors for individuals with type 2 diabetes with and without cardiovascular-renal disease in South Korea, 2015-2021.

本文引用的文献

1
Advances in the treatment of diabetic retinopathy.糖尿病性视网膜病变的治疗进展。
J Diabetes Complications. 2019 Dec;33(12):107417. doi: 10.1016/j.jdiacomp.2019.107417. Epub 2019 Aug 15.
2
Healthcare resource use and costs of diabetic macular oedema for patients with antivascular endothelial growth factor versus a dexamethasone intravitreal implant in Korea: a population-based study.韩国抗血管内皮生长因子与地塞米松玻璃体内植入物治疗糖尿病性黄斑水肿患者的医疗资源利用和成本:一项基于人群的研究。
BMJ Open. 2019 Sep 20;9(9):e030930. doi: 10.1136/bmjopen-2019-030930.
3
Diabetes Fact Sheets in Korea, 2018: An Appraisal of Current Status.
2015 - 2021年韩国2型糖尿病伴或不伴心血管肾脏疾病患者使用钠-葡萄糖协同转运蛋白2抑制剂的处方趋势
J Diabetes Investig. 2025 Feb;16(2):215-224. doi: 10.1111/jdi.14363. Epub 2024 Nov 22.
4
To Determine the Risk-Based Screening Interval for Diabetic Retinopathy: Development and Validation of Risk Algorithm from a Retrospective Cohort Study.确定糖尿病视网膜病变基于风险的筛查间隔:一项回顾性队列研究中风险算法的开发与验证
Diabetes Metab J. 2025 Mar;49(2):286-297. doi: 10.4093/dmj.2024.0142. Epub 2024 Oct 31.
5
Trends and Barriers in Diabetic Retinopathy Screening: Korea National Health and Nutritional Examination Survey 2016-2021.糖尿病视网膜病变筛查的趋势与障碍:韩国2016 - 2021年国家健康与营养检查调查
J Korean Med Sci. 2024 Jul 15;39(27):e203. doi: 10.3346/jkms.2024.39.e203.
6
Variations in Electronic Health Record-Based Definitions of Diabetic Retinopathy Cohorts: A Literature Review and Quantitative Analysis.基于电子健康记录的糖尿病视网膜病变队列定义的差异:文献综述与定量分析
Ophthalmol Sci. 2024 Jan 24;4(4):100468. doi: 10.1016/j.xops.2024.100468. eCollection 2024 Jul-Aug.
7
Present and future screening programs for diabetic retinopathy: a narrative review.糖尿病视网膜病变的当前及未来筛查项目:一篇叙述性综述
Int J Retina Vitreous. 2024 Feb 3;10(1):14. doi: 10.1186/s40942-024-00534-8.
8
Chronic disease management program applied to type 2 diabetes patients and prevention of diabetic complications: a retrospective cohort study using nationwide data.慢性病管理方案应用于 2 型糖尿病患者和预防糖尿病并发症:一项使用全国性数据的回顾性队列研究。
BMC Public Health. 2023 May 23;23(1):928. doi: 10.1186/s12889-023-15763-z.
9
Visual Acuity Outcomes in Diseases Associated with Reduced Visual Acuity: An Analysis of the National Health Insurance Service Database in Korea.与低视力相关疾病的视力结局:韩国国家健康保险服务数据库分析。
Int J Environ Res Public Health. 2022 Jul 17;19(14):8689. doi: 10.3390/ijerph19148689.
10
Prevalence of Diabetic Retinopathy in Undiagnosed Diabetic Patients: A Nationwide Population-Based Study.未诊断糖尿病患者中糖尿病视网膜病变的患病率:一项全国范围内基于人群的研究。
Diabetes Metab J. 2022 Jul;46(4):620-629. doi: 10.4093/dmj.2021.0099. Epub 2022 Feb 23.
韩国糖尿病概况手册 2018:现状评估。
Diabetes Metab J. 2019 Aug;43(4):487-494. doi: 10.4093/dmj.2019.0067. Epub 2019 Jul 17.
4
Ranibizumab Induces Regression of Diabetic Retinopathy in Most Patients at High Risk of Progression to Proliferative Diabetic Retinopathy.雷珠单抗可使大多数有进展为增殖性糖尿病视网膜病变高风险的患者的糖尿病视网膜病变发生消退。
Ophthalmol Retina. 2018 Oct;2(10):997-1009. doi: 10.1016/j.oret.2018.06.005. Epub 2018 Aug 1.
5
Evaluating the Impact of Intravitreal Aflibercept on Diabetic Retinopathy Progression in the VIVID-DME and VISTA-DME Studies.在VIVID-DME和VISTA-DME研究中评估玻璃体内注射阿柏西普对糖尿病性黄斑水肿进展的影响。
Ophthalmol Retina. 2018 Oct;2(10):988-996. doi: 10.1016/j.oret.2018.02.011. Epub 2018 Mar 31.
6
Trends of Diabetes Epidemic in Korea.韩国糖尿病流行趋势。
Diabetes Metab J. 2018 Oct;42(5):377-379. doi: 10.4093/dmj.2018.0194.
7
Past and Current Status of Adult Type 2 Diabetes Mellitus Management in Korea: A National Health Insurance Service Database Analysis.韩国成人2型糖尿病管理的过去与现状:一项国民健康保险服务数据库分析
Diabetes Metab J. 2018 Apr;42(2):93-100. doi: 10.4093/dmj.2018.42.2.93.
8
Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab.两年内糖尿病视网膜病变的变化:比较阿柏西普、贝伐单抗和雷珠单抗的随机临床试验的二次分析
JAMA Ophthalmol. 2017 Jun 1;135(6):558-568. doi: 10.1001/jamaophthalmol.2017.0821.
9
Trends in diabetic retinopathy and related medical practices among type 2 diabetes patients: Results from the National Insurance Service Survey 2006-2013.2006-2013 年国家保险服务调查:2 型糖尿病患者中糖尿病视网膜病变及相关医疗实践的趋势。
J Diabetes Investig. 2018 Jan;9(1):173-178. doi: 10.1111/jdi.12655. Epub 2017 Jun 15.
10
Treatment of diabetic retinopathy: Recent advances and unresolved challenges.糖尿病视网膜病变的治疗:最新进展与未解决的挑战
World J Diabetes. 2016 Aug 25;7(16):333-41. doi: 10.4239/wjd.v7.i16.333.